Horizons Ventures

Horizon Ventures is a Hong Kong-based venture capital firm established in 2002, specializing in technology-focused investments across various sectors. With a global presence, the firm targets seed, early-stage, and late-stage opportunities, particularly in artificial intelligence, machine learning, fintech, healthcare technology, and software as a service (SaaS). Horizon Ventures is known for its disruptive investment strategy, having achieved notable exits in successful companies such as Skype, Siri, Facebook, Summly, and Waze. Through its strategic investments, the firm aims to support innovative startups that have the potential to reshape their respective industries.

Debbie Chang

Founder

Solina Chau

Co-Founder

Mabel Chu

Managing Director

Frances Kang

Investor

Tony Lau

Investment Professional

Ivan Lee

Investor

Jason Wong

Director

Patrick Zhang

Investor

Past deals in Australasia

Soul Machines

Series B in 2022
Soul Machines Limited specializes in creating emotionally responsive avatars that enhance user interactions with artificial intelligence platforms. Founded in 2016 and headquartered in Auckland, New Zealand, the company also operates offices in major cities including San Francisco, New York, London, Tokyo, and Melbourne. Its flagship product, Digital DNA Studio, empowers users to design custom digital personas for various applications, including customer care, marketing, education, and training. By leveraging advanced technology, Soul Machines aims to redefine customer engagement and promote deeper interactivity, ultimately transforming how individuals interact with machines and brands. The company's innovative approach focuses on creating empathetic AI assistants that facilitate meaningful human-machine collaboration, enhancing overall user experiences across multiple sectors, from retail to healthcare.

Fertilis

Seed Round in 2022
Fertilis is a company focused on enhancing the in vitro fertilization (IVF) experience for both patients and clinicians. It specializes in developing innovative IVF technology that automates cell culture using micromedical devices. This technology standardizes and automates the IVF process, ensuring better protection for embryos. By utilizing patented micro-3D printed pods, Fertilis creates an optimized growth environment that improves the nutritive composition of solutions used during embryo cultivation. This approach aims to make the IVF process less stressful and more successful, benefiting medical professionals and their patients alike.

Harrison.ai

Series B in 2021
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools that integrate into existing clinical workflows which ultimately lead to improved patient outcomes. Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images. Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients. Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.

Q-CTRL

Series B in 2021
Q-CTRL Pty Ltd, established in 2017 and located in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. The company focuses on addressing critical challenges in quantum technology, such as noise and decoherence, which affect the performance of quantum devices. By leveraging its expertise in quantum control engineering, Q-CTRL provides intuitive software solutions designed to reduce errors in quantum bits, thereby stabilizing quantum hardware. Its offerings are particularly relevant in the NISQ (Noisy Intermediate-Scale Quantum) era, allowing users to better understand and manage the impacts of noise and errors in quantum systems. Through its innovative approach, Q-CTRL aims to make quantum technology more practical and accessible for various applications, including quantum sensing in defense.

Fleet Space Technologies

Series B in 2021
Fleet Space Technologies Pty Ltd is an Australian company that designs, builds, and launches a network of small satellites to provide global satellite connectivity for the Internet of Things (IoT). Founded in 2015 and based in Beverley, the company focuses on delivering low-cost, secure, and efficient connectivity solutions for various sectors, including mining, oil and gas, precision agriculture, and transportation. By utilizing a fleet of tiny satellites, Fleet Space enables machine-to-machine data exchange and the deployment of IoT sensor networks at scale. The platform facilitates simple device setup and management through a web interface, enhancing resource efficiency and supporting the growth of IoT applications worldwide.

Loam Bio

Series A in 2021
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.

Prospection

Series B in 2021
Prospection Pty Ltd, founded in 2012 and based in Sydney, Australia, specializes in healthcare data analytics through its software as a service (SaaS) platforms. The company offers solutions such as PharmDash, which provides real-world evidence by analyzing patient treatment regimens and drug effectiveness, and PharmMap, which integrates commercial and operational data using geospatial mapping. Prospection employs predictive analytics and machine learning to derive insights from extensive healthcare data, assisting pharmaceutical companies, research institutes, and healthcare providers in improving patient outcomes. The company collaborates with various stakeholders in over 70 therapy programs, including immuno-oncology and infectious diseases, primarily within Australia and the Asia Pacific region.

v2food

Series B in 2021
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

v2food

Series B in 2020
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

Loam Bio

Seed Round in 2020
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.

Prospection

Series A in 2020
Prospection Pty Ltd, founded in 2012 and based in Sydney, Australia, specializes in healthcare data analytics through its software as a service (SaaS) platforms. The company offers solutions such as PharmDash, which provides real-world evidence by analyzing patient treatment regimens and drug effectiveness, and PharmMap, which integrates commercial and operational data using geospatial mapping. Prospection employs predictive analytics and machine learning to derive insights from extensive healthcare data, assisting pharmaceutical companies, research institutes, and healthcare providers in improving patient outcomes. The company collaborates with various stakeholders in over 70 therapy programs, including immuno-oncology and infectious diseases, primarily within Australia and the Asia Pacific region.

Soul Machines

Series B in 2020
Soul Machines Limited specializes in creating emotionally responsive avatars that enhance user interactions with artificial intelligence platforms. Founded in 2016 and headquartered in Auckland, New Zealand, the company also operates offices in major cities including San Francisco, New York, London, Tokyo, and Melbourne. Its flagship product, Digital DNA Studio, empowers users to design custom digital personas for various applications, including customer care, marketing, education, and training. By leveraging advanced technology, Soul Machines aims to redefine customer engagement and promote deeper interactivity, ultimately transforming how individuals interact with machines and brands. The company's innovative approach focuses on creating empathetic AI assistants that facilitate meaningful human-machine collaboration, enhancing overall user experiences across multiple sectors, from retail to healthcare.

Harrison.ai

Series A in 2019
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools that integrate into existing clinical workflows which ultimately lead to improved patient outcomes. Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images. Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients. Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.

v2food

Series A in 2019
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

Q-CTRL

Series A in 2019
Q-CTRL Pty Ltd, established in 2017 and located in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. The company focuses on addressing critical challenges in quantum technology, such as noise and decoherence, which affect the performance of quantum devices. By leveraging its expertise in quantum control engineering, Q-CTRL provides intuitive software solutions designed to reduce errors in quantum bits, thereby stabilizing quantum hardware. Its offerings are particularly relevant in the NISQ (Noisy Intermediate-Scale Quantum) era, allowing users to better understand and manage the impacts of noise and errors in quantum systems. Through its innovative approach, Q-CTRL aims to make quantum technology more practical and accessible for various applications, including quantum sensing in defense.

Fleet Space Technologies

Series A in 2019
Fleet Space Technologies Pty Ltd is an Australian company that designs, builds, and launches a network of small satellites to provide global satellite connectivity for the Internet of Things (IoT). Founded in 2015 and based in Beverley, the company focuses on delivering low-cost, secure, and efficient connectivity solutions for various sectors, including mining, oil and gas, precision agriculture, and transportation. By utilizing a fleet of tiny satellites, Fleet Space enables machine-to-machine data exchange and the deployment of IoT sensor networks at scale. The platform facilitates simple device setup and management through a web interface, enhancing resource efficiency and supporting the growth of IoT applications worldwide.

Q-CTRL

Seed Round in 2017
Q-CTRL Pty Ltd, established in 2017 and located in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. The company focuses on addressing critical challenges in quantum technology, such as noise and decoherence, which affect the performance of quantum devices. By leveraging its expertise in quantum control engineering, Q-CTRL provides intuitive software solutions designed to reduce errors in quantum bits, thereby stabilizing quantum hardware. Its offerings are particularly relevant in the NISQ (Noisy Intermediate-Scale Quantum) era, allowing users to better understand and manage the impacts of noise and errors in quantum systems. Through its innovative approach, Q-CTRL aims to make quantum technology more practical and accessible for various applications, including quantum sensing in defense.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.